Evidence map›Paper›PMID 40119107›Full record

ArticleScientific reports2025

Efficiency of genome editing using modified single-stranded oligodeoxyribonucleotides in human cells.

Seryoung Kim, Yosuke Matsushita, Toyomasa Katagiri, Hideaki Maseda

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Seryoung KimBiomedical Research Institute, National Institute of Advanced Industrial Science and Technology, 1-8- 31 Midorigaoka, Ikeda, 563-8577, Osaka, Japan.
Yosuke MatsushitaDivision of Genome Medicine, Institute of Advanced Medical Sciences, Tokushima University, 3-18-18 Kuramotocho, Tokushima, 770-8503, Japan.
Toyomasa KatagiriDivision of Genome Medicine, Institute of Advanced Medical Sciences, Tokushima University, 3-18-18 Kuramotocho, Tokushima, 770-8503, Japan.
Hideaki MasedaBiomedical Research Institute, National Institute of Advanced Industrial Science and Technology, 1-8- 31 Midorigaoka, Ikeda, 563-8577, Osaka, Japan. maseda.h@aist.go.jp.

Funding

Japan Agency for Medical Research and Development JP20ck0106410Japan Society for the Promotion of Science JP20K20640
6 · The paper itself

Abstract

Single-stranded oligodeoxyribonucleotide (ssODN) gene editing has emerged as a promising therapeutic strategy. However, further improvements in efficiency are desired for practical application. The effects of strand length and locked nucleic acid (LNA) modification on ssODN genome editing were investigated by introducing an assay cassette into the genome of HEK293T cells and measuring precise base deletions of eight bases. The introduction of LNAs into ssODNs, five pairs of LNAs at 25-35 nt from the centre and one pair at 20-25 nt, showed approximately 18-fold higher efficiency than unmodified ssODNs of the same length in the study using 70 nt ssODNs. In addition, genome editing efficiency was further improved when LNAs were introduced at the same positions as the 70 nt ssODN, which showed the highest efficiency for the 90 nt ssODN. However, in some cases, the same number of LNA modifications could conversely reduce the efficiency, and the modification positions in the ssODN method were successfully optimised in the present study. Furthermore, the oligo DNA was shown to be effective not only for deletions but also for base substitutions, with an editing efficiency of 0.63% per cell.

Indexed as

DNA, Single-StrandedGene EditingGenome, HumanOligodeoxyribonucleotidesCRISPR-Cas SystemsHEK293 CellsHumansOligonucleotidesDNA, Single-Strandedlocked nucleic acidOligodeoxyribonucleotidesOligonucleotides

Identifiers

PMID40119107
PMCPMC11928489

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.